Further processing options
PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing brea...
Saved in:
| Published in: | Journal of clinical oncology 32(2014), 29, Seite 3212-3222 |
|---|---|
| Authors and Corporations: | , , |
| Title: | PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer/ Sibylle Loibl, Gunter von Minckwitz, Andreas Schneeweiss, Stefan Paepke, Annika Lehmann, Mahdi Rezai,Dirk M. Zahm, Peter Sinn, Fariba Khandan, Holger Eidtmann, Karel Dohnal, Clemens Heinrichs, Jens Huober, Berit Pfitzner, Peter A. Fasching, Fabrice Andre, Judith L. Lindner, Christos Sotiriou, August Dykgers, Sanxing Guo, Stephan Gade, Valentina Nekljudova, Sherene Loi, Michael Untch, and Carsten Denkert |
| Type of Resource: | E-Book Component Part |
| Language: | English |
| published: |
8 September 2014
|
| Series: |
: Journal of clinical oncology, 32(2014), 29, Seite 3212-3222
, volume:32 |
| Source: | Verbunddaten SWB Lizenzfreie Online-Ressourcen |
Loading...